Onco BCG 40 mg Injection
9,73$
9,40$
Onco BCG 40 mg Injection is an effective therapeutic option for patients diagnosed with early-stage bladder cancer, particularly for those whose tumors have not invaded the bladder muscle. This innovative vaccine functions by targeting and eliminating cancerous cells while significantly reducing the risk of cancer recurrence, thereby aiding in long-term management of the disease. Administered directly into the bladder, Onco BCG stimulates the immune system to recognize and attack malignant cells, fostering a proactive response against bladder cancer. Patients should be aware of potential side effects, including mild flu-like symptoms and bladder irritation, which may occur post-treatment. It's crucial to discuss any existing health conditions or medications with a healthcare provider before initiating therapy to ensure safety and effectiveness. With its proven efficacy, Onco BCG is a cornerstone in the fight against bladder cancer, offering hope for improved patient outcomes. Always follow your physician's instructions and attend regular follow-up appointments to monitor progress and address any concerns.
Quantité
Active Pharmaceutical Ingredient
Uses
• Onco bcg 40 mg injection is primarily utilized in the management of early-stage bladder cancer. This form of cancer often arises from the bladder's inner lining and can lead to various symptoms. Patients may experience hematuria, characterized by blood in the urine, which can present as bright red or cola-colored. The use of Onco bcg 40 mg injection helps target cancerous cells, aiming to reduce tumor recurrence.
• In addition to treating early-stage bladder cancer, Onco bcg 40 mg injection is employed to prevent the progression of this disease. Patients who have undergone initial treatment may be at risk for recurrence, making this injection a vital part of their ongoing care. By stimulating the immune system, Onco bcg 40 mg injection plays a crucial role in maintaining remission. This proactive approach is essential for enhancing long-term outcomes for patients.
• Onco bcg 40 mg injection is also beneficial for patients experiencing superficial bladder tumors. These tumors are typically non-invasive but still require careful monitoring and management. The administration of Onco bcg 40 mg injection can help diminish the risk of these tumors returning. This treatment strategy is vital for preserving bladder function and improving the quality of life for affected individuals.
• Lastly, Onco bcg 40 mg injection is indicated for patients with a history of recurrent bladder cancer. The recurrence of cancer can be distressing and requires effective intervention. By using Onco bcg 40 mg injection, healthcare providers aim to bolster the patient's immune response against cancer cells. This treatment serves as a critical component in the comprehensive management of bladder cancer.
Benefits
Onco BCG 40 mg is effective in preventing the recurrence of early-stage bladder cancer. Bacillus Calmette-Guérin BCG Injection is administered directly into the bladder via a catheter, which means that there is no need for surgery or other invasive procedures. Onco BCG 40 mg Injection will provide long-lasting protection against the recurrence of early-stage bladder cancer.
Side Effects
The majority of side effects will resolve on their own as the body adjusts to the treatment, and medical attention is not usually necessary. However, if these side effects persist or cause concern, it is recommended that you consult your doctor for further evaluation and guidance.
Most Common Side Effects
• Injection site redness, and swelling.
Common Side Effects
• Difficulty in urination
• Urinary tract infection
• Fever
How To Use
The Onco BCG 40 mg Injection is given by a doctor or nurse in a clinical setting, and it is directly injected into the urinary bladder via a catheter. To ensure effectiveness, it is important to complete the full course of the Onco BCG 40 mg even if symptoms improve before the course is finished. You should not discontinue even if you get better until the course is completed.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Anti-TB Vaccine BCG. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Patients with kidney disease should closely monitor kidney function while taking Onco BCG Vaccine and report any unusual symptoms or changes in kidney function to their physician. The dose of Onco BCG 40 mg Injection should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Onco BCG Vaccine. Onco BCG 40 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Onco BCG 40 mg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: It is important to use caution when taking Bacillus Calmette-Guérin BCG Injection if you have liver disease, as the dose of the medication may need to be adjusted. It is recommended to consult with your doctor about the appropriate use of this medication in your specific situation.
• Pregnancy: Use of Onco BCG 40 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Onco BCG 40 mg Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Onco BCG 40 mg Injection is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Onco BCG 40 mg, such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.